Activation of microglia cells is dispensable for the induction of rat retroviral spongiform encephalopathy
Tóm tắt
In the course of retroviral CNS infections, microglia activation has been observed frequently, and it has been hypothesized that activated microglia produce and secrete neurotoxic products like proinflammatory cytokines, by this promoting brain damage. We challenged this hypothesis in a rat model for neurodegeneration. In a kinetic study, we found that microglia cells of rats neonatally inoculated with neurovirulent murine leukemia virus (MuLV) NT40 became infected in vivo to maximal levels within 9–13 days postinoculation (bdd.p.i.). Beginning from 13 d.p.i., degenerative alterations, i.e., vacuolization of neurons and neuropil were found in cerebellar and other brain-stem nuclei. Elevated numbers of activated microglia cells—as revealed by immunohistochemical staining with monoclonal antibody EDI—were first detected at 19 d.p.i. and were always locally associated with degenerated areas but not with nonaltered, yet infected, brain regions. Both neuropathological changes and activated microglia cells increased in intensity and numbers, respectively, with ongoing infection but did not spread to other than initially affected brain regions. By ribonuclease protection assays, we were unable to detect differences in the expression levels of tumor-necrosis-factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in microglia cells nor in total brains from infected versus uninfected rats. Our results suggest that the activation of microglia in the course of MuLV neurodegeneration is rather a reaction to, and not the cause of, neuronal damage. Furthermore, overt expression of the proinflammatory cytokines TNF-α, IL-1β, and IL-6 within the CNS is not required for the induction of retroviral associated neurodegeneration in rats.
Tài liệu tham khảo
An S, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F (1996). Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 91: 494–503.
Askovic S, McAtee F, Favara C, Portis J (2000). Brain infection by neuroinvasive but avirulent murine oncornaviruses. J Virol 74: 465–473.
Baszler TV, Zachary JF (1990). Murine retroviral-induced spongiform neuronal degeneration parallels resident microglial cell infection. Lab Invest 63: 612–623.
Benveniste E (1997). Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75: 165–173.
Berman N, Marcario J, Yong C, Raghavan R, Raymond L, Joag S, Narayan O, Cheney P (1999). Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes. Neurobiol Dis 6: 486–498.
Boje K, Arora P (1992). Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587: 250–256.
Brinkmann R, Schwinn A, Müller J, Stahl-Hennig C, Coulibaly C, Hunsmann G, Czub S, Rethwilm A, Dörries R, ter Meulen V (1993). In vitro and in vivo Infection of Rhesus monkey microglial cells by simian immunodeficiency virus. Virology 195: 561–568.
Brinkmann R, Schwinn A, Narayan O, Zink C, Kreth H, Roggendorf W, Dörries R, Schwender S, Imrich H, ter Meulen V (1992). Human immunodeficiency virus in microglia: Correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol 31: 361–365.
Chao C, Hu S, Molitor T, Shaskan E, Peterson P (1992). Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149: 2736–2741.
Choe W, Stoica G, Lynn W, Wong P (1998). Neurodegeneration induced by MoMuLV-ts1 and increased expression of Fas and TNF-alpha in the central nervous system. Brain Res 779: 1–8.
Czub M, Czub S, McAtee FJ, Portis JL (1991). Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J Virol 65: 2539–2544.
Czub M, Czub S, Rappold M, Mazgareanu S, Schwender S, Demuth M, Hein A, Dörries R (1995). Murine leukemia virus induced neurodegeneration of rats: enhancement of neuropathogenicity correlates with enhanced viral tropism for macrophages, microglia, and brain vascular cells. Virology 214: 239–244.
Czub S, Czub M, Madlon H, Müller J (2000). Proliferation of cortical microglia and lymphocytic polioencephalitis accompanies pre-symptomatic SIV infection. Submitted.
Czub S, Müller J, Czub M, Müller-Hermelink H-K (1996). Nature and sequence of Simian Immunodeficiency Virus-induced central nervous system lesions: a kinetic study. Acta Neuropathol 92: 487–498.
Dawson V, Dawson T, Uhl G, Snyder S (1993). Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90: 3256–3259.
Dickson D, Lee S, Hatch W, Mattiace L, Brosnan C, Lyman W (1994). Macrophages and microglia in HIV-related CNS neuropathology. Res Publ Assoc Res Nerv Ment Dis 72: 99–118.
Dickson D, Lee S, Mattiace L, Yen S, Brosnan C (1993). Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease. Glia 7: 75–83.
Dickson D, Mattiace L, Kure K, Hutchins K, Lyman W, Brosnan C (1991). Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 64: 135–156.
Dijkstra C, Dopp E, Joling P, Kraal G (1985). The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. Adv Exp Med Biol 186: 409–419.
Eikelenboom P, Veerhuis R (1996). The role of complement and activated microglia in the pathogenesis of Alzheimer’s disease. Neurobiol Aging 17: 673–680.
Giese A, Brown D, Groschup M, Feldmann C, Haist I, Kretzschmar H (1998). Role of microglia in neuronal cell death in prion disease. Brain Pathol 8: 449–457.
Glass J, Fedor H, Wesselingh S, McArthur J (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762.
Gonzalez-Scarano F, Baituch G (1999). Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219–240.
Gravel C, Kay DG, Jolicoeur P (1993). Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J Virol 67: 6648–6658.
Grimaldi L, Martino G, Franciotta D, Brustia R, Castagna A, Pristera R, Lazzarin A (1991). Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 29: 21–25.
Hansen R, Czub S, Werder E, Herold J, Gosztonyi G, Gelderblom H, Schimmer S, Mazgareanu S, ter Meulen V, Czub M (2000). Abundant defective viral particles budding from microglia in the course of retroviral spongiform encephalopathy. J Virol 74: 1775–1780.
Kai K, Furuta T (1984). Isolation of paralysis-inducing murine leukemia viruses from friend virus passaged in rats. J Virol 50: 970–973.
Kong L, Wilson B, McMillian M, Bing G, Hudson P, Hong J (1996). The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 172: 77–83.
Laverda A, Gallo P, De Rossi A, Sivieri S, Cogo P, Pagliaro A, Chieco-Bianchi L, TavolatoB (1994). Cerebrospinal fluid analysis in HIV-1-infected children: immunological and virological findings before and after AZT therapy. Acta Paediatr 83: 1038–1042.
Lawson L, Perry V, Dri P, Gordon S (1991). Heterogeneity in the distribution and morphology of microglia in the normal, adult mouse brain. Neuroscience 39: 151–170.
Lotan M, Schwartz M (1994). Cross talk between the immune system and the nervous system in response to injury: implications for regeneration. FASER J 13: 1026–1033.
Lynch W, Czub S, McAttee F, Hayes S, Portis J (1991). Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 7: 365–379.
Lynch W, Robertson S, Portis J (1995). Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. J Virol 69: 1408–1419.
Merrill J, Ignarro L, Sherman M, Melinek J, Lane T (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132–2141.
Nagra R, Heyes M, Wiley C (1994). Viral load and its relationship to quinolic acid, TNFα, and IL-6 levels in the CNS of retroviral infected mice. Mol Chem Neuropathol 22: 143–160.
Oleszak E, Katsetos C, Kuzmak J, Varadhachary A (1997). Inducible nitric oxide synthase in Theiler’s murine encephalomyelitis virus infection. J Virol 71: 3228–3235.
Perrella O, Carrieri P, Guarnaccia D, Soscia M (1992). Cerebrospinal fluid cytokines in AIDS dementia complex. J Neurol 239: 387–388.
Piani D, Spranger M, Frei K, Schaffner A, Fontana A (1992). Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 9: 2429–2436.
Portis J, Lynch W (1998). Dissecting the determinants of neuropathogenesis of the murine oncornaviruses. Virology 247: 127–136.
Portis JL, Czub S, Garon CF, McAtee FJ (1990). Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective friend murine leukemia virus. J Virol 64: 1648–1656.
Rabchevsky A, Streit W (1997). Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J Neurosci Res 47: 34–48.
Robertson S, Hasenkrug K, Chesebro B, Portis J (1997). Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells. J Virol 71: 5287–5294.
Sauder C, de la Torre J (1999). Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection. J Neuroimmunol 96: 29–45.
Schöbitz B, De Kloet E, Holsboer F (1994). Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 44: 397–432.
Scilhean D, Kobayashi K, He Y, Uchihara T, Rosenblum O, Katlama C, Bricaire F, Duyckaerts C, Hauw J (1997). Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol 93: 508–517.
Sopper S, Demuth M, Stahl-Hennig C, Hunsmann G, Plesker R, Coulibaly C, Czub S, Ceska M, Koutsilieri E, Riederer P, Brinkmann R, Katz M, ter Meulen V (1996). The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from Rhesus monkey. Virology 220: 320–329.
Streit W, Sharon A, Pennell N (1999). Reactive microgliosis. Prog Neurobiol 57: 563–581.
Toggas S, Masliah E, Rockenstein E, Rall G, Abraham C, Mucke L (1994). Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188–193.
Tyor W, Glass J, Baumrind N, McArthur J, Griffin J, Becker P, Griffin D (1993). Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43: 1002–1009.
Tyor W, Glass J, Griffin J, Becker P, McArthur J, Bezman L, Griffin D (1992). Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31: 349–360.
Weis S, Neuhaus B, Mehraein P (1994). Activation of microglia in HIV-1 infected brains is not dependent on the presence of HIV-1 antigens. Neuroreport 5: 1514–1516.
Wesselingh S, Takahashi K, Glass J, McArthur J, Griffin J, Griffin D (1997). Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/ polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol 74: 1–8.
Zujovic V, Benavides J, Vige X, Carter C, Taupin V (2000). Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29: 305–315.